Figure S9 from A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor

Rebecca Burchett; Claire G. Morris; Mira Ishak; Nickolas J. Serniuck; Derek T. Cummings; Christopher L. Baker; Ricardo M. Marius; Natasha Kazdhan; Christopher M. Silvestri; John Bell; Brian Dennis Lichty; Scott R. Walsh; Yonghong Wan; Joanne A. Hammill; Jonathan L. Bramson

doi:10.1158/2326-6066.31239029

Figure S9 from A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor

2026 Open access

Read full text

Authors: Rebecca Burchett, Claire G. Morris, Mira Ishak, Nickolas J. Serniuck, Derek T. Cummings, Christopher L. Baker, Ricardo M. Marius, Natasha Kazdhan, Christopher M. Silvestri, John Bell, Brian Dennis Lichty, Scott R. Walsh

+3 more

Yonghong Wan, Joanne A. Hammill, Jonathan L. Bramson

DOI: 10.1158/2326-6066.31239029

Cited by: 0

Abstract

Figure S9. Generation and validation of dual-expression hBCMAtNGFR/red-shifted luciferase (rsLuc) constructs for in vivo VSV tracking studies.

Fields of Study & Subjects

CAR-T cell therapy research Immunotherapy and Immune Responses Virus-based gene therapy research

Publication details

Publication date: 3 February 2026